Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Dispatch

Lyme Disease in Hispanics, United States, 2000–2013

Christina A. NelsonComments to Author , J. Andrew Starr, Kiersten J. Kugeler, and Paul S. Mead
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (C.A. Nelson, K.J. Kugeler, P.S. Mead); University of Virginia School of Medicine, Charlottesville, Virginia, USA (J.A. Starr)

Main Article

Table 1

Demographic and clinical characteristics of Hispanics and non-Hispanics with LD, United States, 2000–2013*

Characteristic Hispanic, n = 5,473 Non-Hispanic, n = 142,971 RR (95% CI) p value
Male sex† 2,982 (54.8) 78,417 (55.0) 1.00 (0.97–1.02)
Median age, y (IQR)
32 (15–46)
42 (16–58)

0.0001‡
Disease onset
Total with known date of disease onset 3,826 (69.9) 116,600 (82.6)
Summer months, Jun-Aug 2,170 (56.7) 77,548 (66.5) 0.85 (0.83–0.88)
Fall months, Sep–Nov
637 (16.7)
16,821 (14.4)
1.15 (1.07–1.24)

Clinical features
Total with information on clinical features 2,696 (49.3) 90,180 (63.1)
Erythema migrans 1,605 (59.5) 64,660 (71.7) 0.83 (0.80–0.86)
Arthritis 854 (31.7) 25,647 (28.4) 1.11 (1.05–1.18)
Facial palsy 391 (14.5) 7,529 (8.4) 1.74 (1.58–1.91)
Atrioventricular block 36 (1.3) 952 (1.1) 1.26 (0.91–1.76)
Meningitis
36 (1.3)
1,026 (1.1)
1.17 (0.84–1.63)

Residence in high-incidence state§ 4,937 (90.2) 130,305 (91.1) 0.90 (0.82–0.98)

*Values are no. (%) unless otherwise indicated. Statistically significant differences between the comparison groups are in bold. IQR, interquartile range; LD, Lyme disease; RR, risk ratio.
†Percentage of persons with LD for whom sex is known (n = 5,442 Hispanics, n = 142,625 non-Hispanics).
‡The substantial difference in median age between the US Hispanic population (27 y) and the US non-Hispanic population (42 y) most likely accounts for the difference seen here.
§Defined as 1 of the 13 highest-incidence states that accounted for 95% of all reported confirmed cases of LD in 2010: Connecticut, Delaware, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New York, Pennsylvania, Vermont, Virginia, and Wisconsin.

Main Article

Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external